Chemical activators of PRR21 include a variety of compounds that influence intracellular signaling pathways leading to the protein's activation. Forskolin serves as a direct stimulator of adenylyl cyclase, which catalyzes the conversion of ATP to cyclic AMP (cAMP). Elevated levels of cAMP can activate protein kinase A (PKA), which in turn can phosphorylate PRR21, leading to its activation. Similarly, IBMX, a nonspecific inhibitor of phosphodiesterases, prevents the breakdown of cAMP and cGMP, thereby sustaining PKA activity that can phosphorylate and activate PRR21. Isoproterenol, a beta-adrenergic agonist, also raises cAMP levels, engaging PKA signaling that can target PRR21. Dibutyryl-cAMP, a cAMP analog, bypasses upstream signaling events to directly activate PKA, which may phosphorylate PRR21. Additionally, the PDE4 inhibitor Rolipram increases cAMP levels by specifically inhibiting the phosphodiesterase 4 enzyme, contributing to the activation of PKA and subsequent phosphorylation of PRR21.
In the realm of calcium signaling, ionomycin acts as an ionophore that significantly raises intracellular calcium levels, which can activate PRR21 through calcium/calmodulin-dependent protein kinases (CaMKs). Thapsigargin and FPL 64176 both disrupt calcium homeostasis via different mechanisms; thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump leading to increased cytosolic calcium, while FPL 64176 acts as a calcium channel activator, both resulting in the activation of calcium-dependent kinases that can target PRR21. Bay K8644, another calcium channel agonist, similarly enhances calcium influx, engaging downstream kinases to activate PRR21. Protein kinase C (PKC) activators, such as PMA and the synthetic diacylglycerol analog 1,2-Dioctanoyl-sn-glycerol (DiC8), activate PKC, which can then phosphorylate PRR21. Anisomycin, while primarily known as a protein synthesis inhibitor, can activate stress-activated protein kinases (SAPKs), which may also participate in the phosphorylation and activation of PRR21, linking stress response pathways to the activation of this protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, potentially activating PRR21 through CaMK-dependent phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C which can phosphorylate PRR21, leading to its activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the SERCA pump leading to increased cytosolic calcium levels, which may activate PRR21 through downstream calcium-dependent kinases. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $83.00 | 1 | |
A calcium channel activator that enhances calcium influx, potentially activating PRR21 through calcium-dependent signaling pathways. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
A calcium channel agonist that can activate PRR21 by increasing intracellular calcium and activating calcium-dependent kinases. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterases leading to increased cAMP and cGMP levels, which can activate PRR21 through PKA or PKG activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases, which may lead to PRR21 activation through stress response pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that directly activates PKA, potentially leading to PRR21 activation through phosphorylation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that raises cAMP levels, which can lead to PRR21 activation via PKA signaling. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
A synthetic diacylglycerol (DAG) analog that activates PKC, potentially leading to PRR21 activation through phosphorylation. | ||||||